Bruhova Iva, Zhorov Boris S
Department of Biochemistry and Biomedical Sciences, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada.
BMC Struct Biol. 2007 Jan 29;7:5. doi: 10.1186/1472-6807-7-5.
Correolide, a nortriterpene isolated from the Costa Rican tree Spachea correa, is a novel immunosuppressant, which blocks Kv1.3 channels in human T lymphocytes. Earlier mutational studies suggest that correolide binds in the channel pore. Correolide has several nucleophilic groups, but the pore-lining helices in Kv1.3 are predominantly hydrophobic raising questions about the nature of correolide-channel interactions.
We employed the method of Monte Carlo (MC) with energy minimization to search for optimal complexes of correolide in Kv1.2-based models of the open Kv1.3 with potassium binding sites 2/4 or 1/3/5 loaded with K+ ions. The energy was MC-minimized from many randomly generated starting positions and orientations of the ligand. In all the predicted low-energy complexes, oxygen atoms of correolide chelate a K+ ion. Correolide-sensing residues known from mutational analysis along with the ligand-bound K+ ion provide major contributions to the ligand-binding energy. Deficiency of K+ ions in the selectivity filter of C-type inactivated Kv1.3 would stabilize K+-bound correolide in the inner pore.
Our study explains the paradox that cationic and nucleophilic ligands bind to the same region in the inner pore of K+ channels and suggests that a K+ ion is an important determinant of the correolide receptor and possibly receptors of other nucleophilic blockers of the inner pore of K+ channels.
柯瑞内酯是从哥斯达黎加树木斯帕切亚柯瑞中分离出的一种三萜类化合物,是一种新型免疫抑制剂,可阻断人类T淋巴细胞中的Kv1.3通道。早期的突变研究表明柯瑞内酯结合在通道孔中。柯瑞内酯有几个亲核基团,但Kv1.3中的孔内衬螺旋主要是疏水的,这引发了关于柯瑞内酯与通道相互作用本质的问题。
我们采用能量最小化的蒙特卡罗(MC)方法,在基于Kv1.2的开放Kv1.3模型中寻找柯瑞内酯的最佳复合物,该模型的钾结合位点2/4或1/3/5加载有K+离子。从配体的许多随机生成的起始位置和方向开始,将能量进行MC最小化。在所有预测的低能量复合物中,柯瑞内酯的氧原子螯合一个K+离子。突变分析中已知的柯瑞内酯感应残基以及与配体结合的K+离子对配体结合能有主要贡献。C型失活Kv1.3的选择性过滤器中K+离子的缺乏会使结合K+的柯瑞内酯在内孔中稳定。
我们的研究解释了阳离子和亲核配体结合到K+通道内孔同一区域这一矛盾现象,并表明K+离子是柯瑞内酯受体以及可能是K+通道内孔其他亲核阻滞剂受体的重要决定因素。